Medical Research News

RSS

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Researchers evaluated COVID-19 monoclonal antibody treatment in pregnant and postpartum women.

16 Mar 2022

Prolonged unconsciousness is common in COVID-19 patients, recovery often takes days or even weeks

During the first wave of the COVID-19 pandemic, many patients in intensive care units did not recover consciousness after their breathing tubes were removed and their sedation was stopped, leaving clinicians and families with difficult decisions about whether to continue life-sustaining therapy.

16 Mar 2022

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood.

16 Mar 2022

Neuropsychiatric symptoms develop predominantly due to Alzheimer’s pathology, not cognitive decline

Alzheimer's disease (AD) eventually leads to severe cognitive decline, but most affected individuals also develop distressing neuropsychiatric symptoms.

16 Mar 2022

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Researchers identified curcumin derivatives as potential inhibitors of SARS-CoV-2 enzymes.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Long term exposure to air pollution is linked to a heightened risk of autoimmune disease, particularly rheumatoid arthritis, connective tissue and inflammatory bowel diseases, finds research published online in the open access journal RMD Open.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

Serum folate deficiency in older people may be associated with heightened dementia and death risks

Low levels of folate (vitamin B9) in the blood may be linked to a heightened risk of dementia and death from any cause in older people, suggests research published online in the journal Evidence Based Mental Health.

16 Mar 2022

Novel method can help find the most appropriate exercise therapy for osteoarthritis patients

Osteoarthritis is the most common cause of chronic pain and disability in the world. While no good structure modifying drugs are available to prevent or treat osteoarthritis, various forms of therapeutic exercise have been shown to be useful in relieving pain and improving physical functionality.

16 Mar 2022

Estimating SARS-CoV-2 breakthrough infection numbers in the US

A new study estimated the number of symptomatic COVID-19 breakthrough infections in vaccinated individuals in the US.

16 Mar 2022

Convalescent antibodies do not enhance SARS-CoV-2 infection

Researchers investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 infection.

16 Mar 2022

Financial rewards can be a key motivator for achieving weight loss

With two in three Australian adults currently overweight or obese, and about 47 per cent of Australians now living with related chronic health conditions, an updated report from Australia’s national science agency, CSIRO, has reinforced that personal accountability coupled with financial rewards continue to be a key motivator for achieving weight loss.

16 Mar 2022

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Since the very beginning of the pandemic, there has been concern about the emergence of Guillain-Barré syndrome, a rare disorder where the body's immune system damages nerves. In some cases, nerve damage causes muscle weakness and paralysis.

16 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Researchers used a within-host mathematical model to determine the dynamics of viral RNA and infectious virus titers in both aerosols and the URT.

15 Mar 2022

New findings could change treatment practice and lengthen survival for men with pN1 prostate cancer

Men with microscopic evidence of prostate cancer spreading to their pelvic lymph nodes (LNs) following the surgical resection of the prostate and pelvic lymph nodes (LN) are at a very high risk of dying from prostate cancer. Pelvic LN radiation therapy (RT) is a potentially curative treatment.

15 Mar 2022

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Researchers evaluate the virucidal effects of ELAH against SARS-CoV-2 and human coronavirus-229E in a nasal spray formulation.

15 Mar 2022

Can cardiac biomarkers determine COVID-19 prognosis?

Researchers review prognostic cardiac biomarkers in COVID-19 patients.

15 Mar 2022

Medical Research News

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Prolonged unconsciousness is common in COVID-19 patients, recovery often takes days or even weeks

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Neuropsychiatric symptoms develop predominantly due to Alzheimer’s pathology, not cognitive decline

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Novel targets to inhibit SARS-CoV-2 variants

Serum folate deficiency in older people may be associated with heightened dementia and death risks

Novel method can help find the most appropriate exercise therapy for osteoarthritis patients

Estimating SARS-CoV-2 breakthrough infection numbers in the US

Convalescent antibodies do not enhance SARS-CoV-2 infection

Financial rewards can be a key motivator for achieving weight loss

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

New findings could change treatment practice and lengthen survival for men with pN1 prostate cancer

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Can cardiac biomarkers determine COVID-19 prognosis?

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News